Interactive dashboard | Where COVID-19 vaccine research stands
The great race to a COVID vaccine
This is The Federal’s interactive on the COVID vaccine scenario. Multiple research organisations in various countries are engaged in finding a vaccine for COVID-19. This interactive shows the phase/stage where each research stands. One can simply click on the vaccine name list on the left-hand side to get comprehensive details. Also, hover the cursor over the map to see the progress of vaccine development across countries.
Candidate (select one)
- Covaxin
Candidate
- Bacillus Calmette-Guerin (BCG) live-attenuated vaccine
- AZD1222
- mRNA-1273
- BNT162
- Inactivated vaccine
- BBIBP-CorV
- CoronaVac
- GX-19
- Gam-COVID-Vac
- Ad5-nCoV
- INO-4800
- mRNA-based vaccine
- SCB-2019
- Adjuvant recombinant vaccine candidate
- COVAX-19
- bacTRL-Spike
- PittCoVacc
- Measles vector vaccine
- NVX-CoV2373
- Ii-Key peptide COVID-19 vaccine
- Recombinant vaccine
- Self-amplifying RNA vaccine
- Plant-based COVID-19 vaccine
- DNA-based vaccine
- Ad26.COV2-S
- AdCOVID
- T-COVIDTM
- Protein subunit vaccine
- LUNAR-COV19
- Recombinant vesicular stomatitis virus (rVSV) vaccine
- Adenovirus-based vaccine
- Molecular clamp vaccine
- AAVCOVID
- Recombinant vaccine
- Covaxin
- mRNA lipid nanoparticle (mRNA-LNP) vaccine
- Adenovirus-based vaccine
- gp96-based vaccine
Covaxin
Country
India
Sponsor
Bharat Biotech; National Institute of Virology
Funding
BBIL
Trial Phase
EARLY RESEARCH
PRE-CLINICAL TRIALS
PHASE 1
PHASE 2
PHASE 3
PHASE 4
â–²
Pre-clinical
Phase 0 involves exploratory, first-in-human (FIH) trials that are run according to FDA guidelines. Also called human microdose studies, they have single sub-therapeutic doses given to 10 to 15 subjects and yield pharmacokinetic data or help with imaging specific targets without introducing pharmacological effects. Pharmaceutical companies perform Phase 0 studies to decide which of their drug candidates has the best pharmacokinetic parameters in humans.
